Insights

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Digital transformation surges on, with market sectors as diverse as automotive, consumer packaged goods and healthcare unlocking new revenue streams, greater customer insights and deeper connections with consumers.

There is no doubt that I’ve had a busy few months as head of our medtech division for the Asia Pacific region. As judge for the new MedTech Innovator APAC scheme, I’ve been on the hunt for the best and brightest medical technology start-ups in the region. This process has given me a remarkable insight into the challenges facing the region’s growing healthcare field...
 

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

The past year has seen an unprecedented acceleration of innovation in the diagnostics space. Reflecting on the virtual themes and debates at Molecular Med Tri-Con 2021, Head of Life Sciences Symon Cotton says that the speed of tests and vaccines coming to market is not having an adverse effect on quality. Medical developments can be safely delivered to quicker timescales...